emerg
diseas
andor
pathogen
term
use
frequent
describ
new
spread
infect
human
popul
term
use
describ
emerg
previous
unrecogn
pathogen
produc
human
diseas
recogn
pathogen
expand
differ
way
popul
emerg
diseas
histor
respons
civilizationalt
event
bubon
plagu
centuri
respons
death
european
popul
spanish
flu
pandem
result
death
million
worldwid
rinderpest
epidem
livestock
eastern
africa
centuri
result
starvat
massai
popul
potato
blight
produc
irish
potato
famin
reduc
irish
popul
gener
dramat
experi
last
decad
emerg
reemerg
pathogen
rapidli
spread
result
death
ill
larg
segment
popul
includ
mani
pathogen
mention
section
outlin
book
ebola
zika
virus
clinician
challeng
distinguish
viral
febril
ill
caus
endem
pathogen
one
emerg
potenti
humantohuman
spread
requir
isol
avail
target
therapi
scenario
common
patient
present
emerg
room
usual
weekend
fever
constel
symptom
recent
histori
travel
oversea
fear
ebola
lassa
fever
anoth
unknown
contagi
pathogen
clinician
staff
risk
section
epidemiolog
clinic
featur
evalu
patient
potenti
viral
febril
ill
emerg
pathogen
discuss
increas
time
factor
determin
emerg
virus
includ
high
mutat
rate
adapt
rna
virus
human
intimaci
crossspeci
transmiss
movement
anim
speci
due
land
develop
migrat
polit
conflict
increas
urban
climat
chang
increas
spread
potenti
insect
vector
chang
migratori
pattern
bird
societ
mobil
air
travel
emerg
viral
pathogen
gener
present
one
follow
clinic
categori
gener
febril
ill
produc
viral
syndrom
fever
meningitisenceph
fever
joint
pain
hemorrhag
fever
birth
defect
due
human
host
viral
divers
mani
virus
produc
ill
across
spectrum
clinic
categori
exampl
dengu
viru
first
infect
result
subclin
infect
febril
ill
result
selflimit
fever
myalgia
bone
pain
transient
laboratori
abnorm
second
infect
dengu
viru
minor
patient
produc
sever
hemorrhag
diseas
chikungunya
ross
river
virus
produc
gener
febril
ill
also
sever
joint
pain
persist
month
japanes
enceph
west
nile
equin
enceph
virus
classic
virus
produc
meningoenceph
person
infect
yellow
fever
filovirus
ebola
marburg
exampl
sever
hemorrhag
fever
virus
recent
zika
viru
outbreak
birth
defect
associ
infect
pregnant
women
broaden
clinic
categori
includ
produc
birth
defect
virus
produc
constel
sign
symptom
earli
infect
clinic
infect
incub
period
normal
day
occur
except
exampl
ebola
report
occur
day
exposur
first
onset
symptom
herald
host
immun
respons
fever
follow
gener
symptom
headach
muscl
ach
joint
pain
nausea
vomit
diarrhea
earli
laboratori
abnorm
would
indic
viral
infect
includ
leukopenia
anemia
thrombocytopenia
electrolyt
renal
function
abnorm
common
patient
volum
deplet
diseas
progress
clinic
manifest
becom
specif
clinic
syndrom
provid
clue
potenti
viru
onset
headach
neck
stiff
alter
sensorium
case
enceph
sever
joint
pain
bleed
intern
extern
blood
loss
hemoconcentr
plasma
leakag
hemorrhag
fever
specif
manifest
diuresi
volum
loss
renal
dysfunct
indic
virus
produc
hemorrhag
fever
renal
syndrom
hantavirus
lassa
fever
rash
common
viral
ill
gener
indic
shift
host
immun
respons
cellmedi
humor
immun
respons
rise
antibodi
import
clinician
understand
viremia
occur
sever
day
onset
clinic
ill
durat
earli
clinic
symptom
pathogen
spread
insect
vector
respiratori
rout
bloodborn
contact
sexual
occur
onset
clinic
symptom
thu
infect
other
come
contact
rout
contact
trace
index
patient
includ
day
viremia
onset
symptom
understand
incub
time
viral
pathogen
first
import
step
evalu
febril
patient
travel
histori
area
outbreak
potenti
hot
spot
emerg
diseas
within
incub
period
pathogen
day
exampl
febril
patient
clinic
emerg
room
travel
oversea
month
fever
would
unlik
viral
infect
potenti
etiolog
nonfalciparum
malaria
parasit
infect
consid
extens
travel
histori
exposur
travel
help
determin
risk
patient
acquir
local
infect
import
question
often
ask
els
sick
travel
parti
contact
anyon
acut
ill
often
import
clue
risk
acquir
infect
patient
within
incub
period
risk
viral
ill
determin
clinic
ill
day
import
obtain
histori
studi
hospit
patient
dengu
infect
exampl
illustr
import
clinician
approach
viral
febril
ill
differenti
potenti
virus
determin
patient
clinic
ill
day
clinic
manifest
fig
demonstr
ideal
patient
viral
febril
ill
exampl
incub
period
day
first
day
viremia
occur
viremia
continu
onset
fever
herald
first
day
clinic
ill
gener
first
day
clinic
ill
viral
infect
gener
febril
ill
clinic
sign
symptom
distinguish
ill
specif
viral
pathogen
denot
viral
syndrom
headach
myalgia
nausea
diarrhea
respiratori
symptom
common
viral
syndrom
stage
influenza
dengu
chikungunya
ebola
lassa
fever
indistinguish
earli
clinic
ill
day
clinic
ill
day
day
postinfect
manifest
becom
specif
hemorrhag
manifest
coagulopathi
occur
along
plasma
leakag
enceph
host
respons
increas
antibodi
level
rise
cytokin
peak
manifest
specif
viral
ill
becom
appar
cellular
damag
occur
diagnosi
diagnost
method
use
identifi
viral
pathogen
also
depend
clinic
ill
day
fig
demonstr
timedepend
diagnost
test
perform
clinic
cours
patient
exampl
viremia
start
fever
last
day
clinic
ill
onset
viralspecif
igm
igg
antibodi
viremia
diagnost
test
focus
detect
viru
whether
viral
isol
molecular
techniqu
antigen
detect
viremia
start
resolv
onset
host
respons
correspond
rise
viralspecif
igm
igg
antibodi
continu
rise
convalesc
period
igg
last
sever
year
antibodi
start
rise
diagnost
focus
detect
varieti
method
use
includ
enzymelink
immunoassay
hemagglutin
inhibit
plaqu
reduct
neutral
rapid
test
treatment
control
viru
specif
emphas
need
earli
recognit
order
appropri
diagnost
mani
virus
respons
febril
ill
consid
emerg
emerg
avail
treatment
vaccin
read
specif
virus
chapter
book
give
reader
valuabl
inform
potenti
treatment
vectorborn
zoonot
virus
control
specif
includ
aerial
larvicid
spray
mosquitoborn
virus
person
protect
practic
mosquito
tick
anim
control
zoonoticborn
virus
contact
practic
andor
isol
may
appropri
virus
transmit
human
human
respiratori
virus
crimeancongo
hemorrhag
fever
filovirus
marburg
ebola
dengu
dengu
hemorrhag
fever
human
dengu
cycl
maintain
denv
transmiss
back
forth
mosquito
vector
virem
individu
bite
denvinfect
mosquito
local
viral
replic
langerhan
cell
cutan
dendrit
cell
spread
region
lymph
node
thereaft
viru
rapidli
dissemin
lead
viremia
like
denv
factori
tissu
macrophag
dendrit
cell
adipocyt
incub
period
mosquito
bite
symptom
onset
day
viremia
gener
last
day
disappear
viremia
correl
fever
resolut
sever
sometim
fatal
form
dengu
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
sever
dengu
distinguish
characterist
dhfdss
transient
rapid
increas
vascular
permeabl
plasma
leakag
syndrom
often
character
hemoconcentr
transud
accumul
across
seros
surfac
ie
pleural
effus
ascit
extrem
form
dss
hypovolem
shock
ensu
plasma
leakag
syndrom
dhfdss
develop
rapidli
time
defervesc
clearanc
viremia
transient
hour
day
primari
infect
denv
serotyp
produc
longterm
protect
immun
reinfect
homolog
serotyp
homotyp
immun
shortterm
protect
immun
heterolog
serotyp
heterotyp
immun
rel
risk
develop
dhfdss
sever
dengu
increas
sequenti
heterolog
denv
infect
secondari
denv
infect
compar
primari
denv
infect
individu
secondari
denv
infect
develop
sever
dengu
primari
denv
infect
infant
month
old
also
appear
like
lead
dhfdss
sever
dengu
primari
denv
infect
children
adult
countri
area
risk
dengu
transmiss
distribut
countri
area
risk
dengu
transmiss
worldwid
numer
risk
factor
identifi
develop
sever
dengu
divid
three
gener
step
multipl
risk
factor
combin
take
place
produc
three
step
first
step
includ
factor
increas
dengu
viral
load
includ
antibodydepend
enhanc
viral
infect
impair
tcell
natur
killer
cell
antivir
immun
respons
adipos
viru
genet
serotyp
differ
host
genet
second
step
includ
factor
promot
antidenv
proinflammatori
immun
respons
includ
crossreact
antidenv
tcell
respons
antidenv
iggdenv
immun
complex
adipos
host
genet
final
step
includ
factor
tip
balanc
favor
permeabilityinduc
condit
seros
caviti
sever
proinflammatori
cytokinesmedi
promot
endotheli
paracellular
permeabl
virusinduc
type
interferon
signal
augment
endotheli
barrier
function
three
step
describ
necessari
suffici
produc
sever
dengu
like
outcom
primari
secondari
denv
infect
either
asymptomat
infect
mild
undifferenti
febril
ill
mild
febril
ill
often
character
nonspecif
constitut
symptom
particularli
true
children
wherea
denv
infect
may
like
present
classic
df
adult
classic
df
begin
abrupt
onset
fever
retroorbit
headach
backach
sever
myalgia
breakbon
fever
febril
ill
typic
last
day
accompani
anorexia
nauseavomit
prolong
asthenia
accompani
leukopenia
thrombocytopenia
often
mild
hepat
transaminas
elev
petechia
may
develop
spontan
commonli
elicit
posit
tourniquet
test
clinic
signific
bleed
much
less
common
occasion
sever
life
threaten
toward
end
febril
period
classic
rash
dengu
may
appear
herman
rash
confluent
erythemat
macular
rash
extrem
scatter
wellcircumscrib
area
spare
appear
rash
pathognomon
denv
infect
dhfdss
dengu
clinic
syndrom
whose
distinguish
featur
abrupt
plasma
leakag
intravascular
extravascular
space
world
health
organ
case
definit
dhfdss
incorpor
three
addit
clinic
criteria
beyond
df
establish
grade
scale
iv
dhf
sever
tabl
despit
monik
hemorrhag
fever
often
hemorrhag
manifest
may
posit
tourniquet
test
spontan
skin
mucos
petechia
sever
coagulopathi
nearli
alway
seen
context
profound
shock
multiorgan
failur
recent
guidelin
move
away
dhf
case
definit
instead
propos
new
case
definit
term
sever
dengu
see
tabl
whether
defin
dhfdss
sever
dengu
major
seriou
morbid
mortal
caus
denv
infect
due
vascular
leakag
syndrom
hypotens
shock
clinic
signific
hemorrhag
sometim
occur
absenc
vascular
leakag
particularli
adult
uncommon
complic
denv
infect
includ
hepat
necrosi
encephalopathyenceph
chorioretin
unlik
zika
viru
infect
denv
infect
pregnanc
associ
congenit
malform
dengu
consid
individu
endem
region
particularli
children
present
abruptonset
febril
ill
day
durat
denv
transmiss
season
initi
clinic
find
denv
infect
fairli
nonspecif
difficult
distinguish
common
febril
ill
tropic
differenti
diagnosi
denguelik
ill
includ
typhoid
fever
leptospirosi
rickettsi
infect
malaria
appropri
clinic
set
measl
influenza
chikungunya
zika
viru
infect
also
possibl
earli
febril
cours
suspicion
denv
infect
heighten
presenc
leukopenia
thrombocytopenia
mild
aspart
aminotransferas
elev
posit
tourniquet
test
spontan
petechia
posit
predict
valu
combin
earli
clinic
find
gener
good
dengu
highli
preval
ie
raini
season
critic
phase
denv
infect
hour
surround
defervescencegener
around
day
febril
ill
secondari
denv
infect
time
period
plasma
leakag
take
place
patient
develop
dhfdss
challeng
patient
dengu
suspect
dengu
identifi
risk
sever
diseas
critic
phase
reach
group
warn
sign
symptom
identifi
denvinfect
patient
often
presag
deterior
dhfdss
sever
dengu
see
tabl
patient
requir
close
monitor
support
care
critic
phase
ill
laboratori
diagnosi
remain
reliabl
way
identifi
denv
infect
revers
transcriptas
polymeras
chain
reaction
rtpcr
detect
viral
rna
blood
day
onset
fever
primari
infect
day
secondari
infect
howev
denv
rtpcr
routin
avail
clinic
set
viremia
also
detect
antigendetect
assay
measur
circul
level
denv
nonstructur
protein
timelin
detect
circul
solubl
lag
viral
rna
rtpcr
detect
day
wide
use
serolog
assay
dengu
igmigg
enzymelink
immunosorb
assay
elisa
singl
posit
dengu
igm
hightit
igg
provid
presumpt
diagnosi
dengu
definit
serolog
diagnosi
requir
pair
acut
convalesc
sera
antidenv
igm
antibodi
level
gener
becom
posit
fifth
sixth
day
ill
affect
flaviviru
infect
eg
japanes
enceph
viru
zika
viru
therefor
diagnost
sensit
specif
antidenv
igm
elisa
assay
often
depend
time
blood
sampl
cocircul
flavivirus
region
manufactur
specif
antivir
therapi
avail
dengu
vast
major
uncompl
dengu
manag
outpati
basi
rest
oral
rehydr
solut
analgesiaantipyret
use
aspirin
nonsteroid
antiinflammatori
drug
nsaid
avoid
exacerb
platelet
dysfunct
mucos
bleed
patient
parent
affect
children
notifi
warn
sign
symptom
prompt
immedi
return
medic
attent
inhospit
manag
arrang
patient
predefin
warn
sign
earli
evid
plasma
leakag
includ
narrow
puls
pressur
bleed
sever
hematolog
abnorm
comorbid
condit
unreli
access
outpati
followup
care
hospit
patient
without
frank
hypotens
shock
key
aspect
support
therapi
judici
intravascular
volum
replac
critic
phase
enter
accomplish
care
administr
intraven
isoton
crystalloid
solut
eg
salin
ringer
lactat
hartmann
solut
frequent
reassess
intravascular
volum
statu
urin
output
overli
aggress
use
intraven
fluid
failur
adequ
monitor
therapi
lead
seriou
complic
fluid
overload
critic
phase
ill
treatment
guidelin
shown
fig
prophylact
platelet
transfus
proven
use
dengu
avoid
platelet
transfus
consid
patient
thrombocytopenia
clinic
signific
hemorrhag
intramuscular
inject
multipl
largebor
intraven
line
diagnost
prophylact
placement
nasogastr
tube
avoid
except
need
sever
case
possibl
complic
unusu
sever
dengu
case
transfer
experienc
referr
center
iv
crystalloid
mlkgh
hour
reduc
mlkgh
hour
reduc
mlkgh
hour
patient
continu
improv
fluid
reduc
monitor
hct
hourli
area
casefat
rate
sever
dengu
earli
recognit
appropri
support
care
manag
dengu
prevent
approach
strategi
minim
humanvector
contact
control
mosquitovector
popul
function
screen
insecticidetr
bed
net
daytim
sleep
eg
infant
reduc
mosquitovector
contact
indoor
person
measur
afford
protect
daytim
bite
habit
femal
aegypti
includ
wear
cloth
minim
skin
exposur
appropri
use
repel
expos
skin
cloth
effect
repel
contain
n
deet
nacetylnbutyl
aminopropion
acid
ethyl
ester
acid
fluid
resuscit
mlkg
isoton
crystalloid
colloid
minut
tri
obtain
hct
level
fluid
resuscit
crystalloidcolloid
mlkgh
hour
continu
iv
crystalloid
mlkgh
hour
reduc
mlkgh
hour
reduc
mlkgh
hour
patient
continu
improv
fluid
reduc
monitor
hct
icaridin
public
health
level
sustain
integr
vectorcontrol
strategi
gener
need
consist
reduc
aegypti
popul
densiti
aegypti
mosquito
prolifer
mani
peridomest
watercontain
habitat
includ
purpos
fill
manmad
contain
eg
water
storag
barrel
flowerpotsvas
rainfil
object
eg
use
tire
natur
habitat
eg
tree
hole
dengu
vaccin
develop
move
forward
encourag
advanc
given
potenti
increas
diseas
sever
upon
sequenti
infect
heterolog
denv
serotyp
gener
consensu
effect
vaccin
strategi
requir
simultan
immun
four
denv
serotyp
tetraval
vaccin
chimer
liveattenu
viral
vaccin
denv
envelop
protein
engin
onto
yellow
fever
yf
vaccin
backbon
licens
sever
countri
howev
vaccin
administ
truli
individu
appear
abl
enhanc
subsequ
diseas
sever
natur
denv
infect
anoth
tetraval
liveattenu
dengu
vaccin
attenu
delet
untransl
region
utr
phase
iii
clinic
trial
dengu
vaccin
product
preclin
earli
clinic
phase
includ
adjuv
recombin
envelop
protein
vaccin
adjuv
inactiv
viru
vaccin
plasmid
dna
vaccin
combin
effect
dengu
vaccin
vectorcontrol
strategi
open
possibl
sever
halt
even
erad
denv
transmiss
mani
endem
region
ann
power
chikungunya
fever
signific
arbovir
diseas
nearli
global
distribut
infect
character
abrupt
onset
high
fever
sever
arthralgia
rash
diseas
nearli
alway
selflimit
rare
fatal
may
result
longterm
arthralgia
affect
qualiti
life
specif
treatment
support
care
consist
treatment
fever
pain
vaccin
yet
exist
vaccin
therapeut
option
develop
aed
aegypti
albopictu
mosquito
endem
mainten
viru
forestdwel
aed
speci
mosquito
chikungunya
chik
fever
arbovir
diseas
character
rapid
onset
high
fever
rash
sever
joint
pain
fig
name
deriv
makond
word
mean
bend
refer
stoop
postur
develop
result
arthrit
symptom
diseas
diseas
nearli
alway
selflimit
bite
infect
mosquito
viru
replic
fibroblast
epitheli
cell
lead
viremia
reach
log
ml
skin
joint
muscl
primari
affect
organ
wherea
nervou
system
heart
liver
less
frequent
involv
macrophag
appear
suscept
infect
virem
phase
mous
model
shown
type
interferon
respons
appear
associ
control
infect
chik
acut
infect
abrupt
onset
herald
high
fever
sever
arthralgia
follow
constitut
symptom
rash
typic
maculopapular
last
period
day
incub
period
usual
day
rang
day
fever
rise
abruptli
often
reach
acut
phase
last
day
week
case
temperatur
may
remit
day
gap
day
result
saddl
back
fever
curv
characterist
arthropodborn
viru
infect
arthralgia
polyarticular
symmetr
predominantli
affect
small
joint
hand
wrist
ankl
feet
see
week
sever
case
requir
month
year
resolv
entir
one
studi
indic
one
third
patient
chronic
joint
symptom
persist
least
month
cutan
manifest
typic
mani
patient
usual
maculopapular
rash
bullou
lesion
occur
infant
trunk
limb
commonli
involv
face
palm
sole
may
also
show
lesion
acut
phase
patient
headach
usual
sever
retroorbit
pain
commonli
found
dengu
infect
rare
occur
conjunctiv
red
present
case
pregnant
women
pass
viru
infant
commonli
intrapartum
phase
reunion
south
hospit
group
observ
pregnant
women
laboratoryconfirm
chik
infect
women
involv
infect
rel
distant
deliveri
newborn
appear
asymptomat
convers
newborn
develop
diseas
soon
birth
meningoenceph
intravascular
coagul
requir
intens
care
support
sever
case
chik
includ
neurolog
complic
myocard
nephriti
occur
commonli
elderli
newborn
immunocompromis
individu
chik
outbreak
typic
result
sever
hundr
thousand
case
death
rare
encount
symptom
chikv
infect
clinic
indistinguish
dengu
fever
caus
differenti
diagnosi
chik
includ
malaria
onyong
nyong
sindbi
ross
river
west
nile
zika
viru
infect
clinic
laboratori
find
chik
remark
patient
may
present
leukopenia
rel
lymphocytosi
howev
patient
normal
blood
count
platelet
count
may
moder
depress
erythrocyt
sediment
rate
creactiv
protein
level
typic
elev
acut
case
definit
diagnosi
made
laboratori
test
chik
suspect
epidem
diseas
occur
characterist
triad
fever
rash
arthralgia
virusspecif
igm
antibodi
typic
detect
day
ill
use
enzymelink
immunosorb
assay
elisa
viremia
high
persist
sever
day
postil
onset
blood
sampl
viru
isol
revers
transcriptas
polymeras
chain
reaction
rtpcr
collect
within
first
day
ill
viremia
detect
frequent
diagnosi
definit
confirm
viru
isol
molecular
techniqu
rtpcr
wide
rang
test
exist
specif
treatment
chik
ill
usual
selflimit
resolv
time
support
care
rest
current
previou
local
transmiss
chikungunya
viru
indic
acut
joint
symptom
movement
mild
exercis
may
decreas
stiff
arthralgia
heavi
exercis
may
exacerb
rheumat
symptom
aspirin
nonsteroid
antiinflammatori
drug
nsaid
recommend
chronic
pain
number
therapeut
option
develop
sever
vaccin
candid
vaccin
specif
medic
yet
avail
chikv
infect
vector
control
import
control
prevent
transmiss
elimin
breed
site
sourc
reduct
import
control
approach
aegypti
typic
containerhabitat
speci
fig
breed
primarili
artifici
contain
receptacl
therefor
water
tank
cistern
barrel
trash
contain
etc
need
cover
tightli
lid
old
tire
tin
can
bucket
drum
bottl
etc
remov
mosquito
may
breed
contain
accumul
water
ornament
garden
water
tank
larvivor
fish
eg
gambusia
guppi
introduc
case
water
contain
empti
daili
weekli
basi
larvicid
treatment
appli
primari
vector
aegypti
albopictu
princip
daytim
biter
insect
repel
contain
n
ndiethylmtoluamid
deet
anoth
regist
activ
ingredi
appli
expos
skin
tabl
peopl
advis
wear
long
sleev
pant
secur
screen
window
door
keep
mosquito
insecticidetr
bed
net
use
daytim
rest
help
prevent
mosquito
bite
infect
person
protect
mosquito
exposur
stay
indoor
andor
mosquito
net
first
day
ill
contribut
transmiss
cycl
higher
percentag
activ
ingredi
provid
longer
protect
epa
search
tool
avail
wwwepagovinsectrepel
findinsectrepellentrighty
infect
spread
primarili
via
infect
femal
mosquito
aegypti
primari
vector
america
albopictu
surviv
temper
area
also
transmit
zika
viru
mosquito
vector
infest
subtrop
tropic
region
global
includ
urban
area
area
total
popul
billion
peopl
season
transmiss
link
local
temperatur
rainfal
pattern
mosquito
also
transmit
dengu
chikungunya
cotransmiss
occur
past
year
zika
transmiss
report
least
countri
zika
viru
transmit
vertic
aegypti
mosquito
transmiss
cycl
america
personmosquitoperson
known
whether
viru
becom
establish
anim
reservoir
host
america
occur
africa
viru
infect
anim
host
occasion
spill
human
populationat
least
past
growth
urban
area
infest
aegypti
provid
suitabl
environ
transmiss
zika
viru
diseas
case
exclud
congenit
case
report
unit
state
januari
decemb
travel
relat
vector
born
case
vector
born
attribut
sexual
transmiss
due
laboratori
transmiss
unknown
rout
http
wwwcdcgovzika
viru
found
blood
urin
saliva
semen
vagin
cervic
secret
sexual
transmiss
occur
symptomat
asymptomat
infect
male
femal
male
male
femal
male
possibl
via
oral
sex
viru
found
vagin
secret
viral
rna
document
semen
day
infect
infecti
viru
day
longitudin
assess
zika
viru
rna
bodi
fluid
men
clear
viru
semen
month
area
infest
compet
vector
difficult
assess
percentag
vector
born
much
infect
sexual
transmit
zika
viru
particl
rna
found
breast
milk
transmiss
via
breastfeed
document
date
viru
persist
longer
whole
blood
plasma
may
relev
diagnosi
test
blood
tissu
donat
transfusiontransplant
transmiss
via
platelet
transfus
report
brazil
rna
zikaposit
asymptomat
donor
identifi
florida
texa
unit
state
screen
blood
donor
puerto
rico
outbreak
island
found
virem
perinat
transmiss
zika
viru
report
occur
french
polynesia
outbreak
associ
zika
viru
microcephali
recogn
observ
made
brazil
retrospect
studi
done
base
serolog
surveil
data
zika
viru
infect
placenta
reach
develop
fetu
target
neural
precursor
matern
infect
disrupt
fetal
central
nervou
system
develop
caus
intrauterin
growth
retard
fetal
loss
infect
associ
cortic
malform
intracrani
calcif
congenit
malform
includ
ventriculomegali
dystroph
calcif
sever
cortic
neuron
deplet
decreas
brain
weight
congenit
contractur
mark
earli
hypertonia
symptom
extrapyramid
involv
ocular
hear
problem
pathologist
also
identifi
pulmonari
hypoplasia
patholog
chang
consist
viral
infect
multipl
organ
includ
liver
kidney
ongo
followup
reveal
extent
development
problem
base
data
us
territori
liveborn
infant
complet
pregnanc
laboratori
evid
possibl
zika
viru
infect
zikaassoci
birth
defect
likelihood
vari
trimest
highest
first
trimest
respect
first
second
third
trimest
zika
viru
seropreval
studi
yap
french
polynesia
estim
asymptomat
infect
rang
clinic
syndrom
among
resid
outbreak
area
yap
french
polynesia
brazil
puerto
rico
return
infect
travel
appear
alik
tabl
frequent
report
symptom
rash
fever
arthriti
andor
arthralgia
myalgia
conjunct
fatigu
common
find
rash
usual
describ
rare
sever
complic
adult
attribut
zika
viru
infect
particularli
neurolog
disord
gb
myeliti
demyelin
polyneuropathi
meningoenceph
autoimmun
disord
immunemedi
thrombocytopenia
gb
occur
zika
infect
studi
french
polynesia
brazil
least
six
time
global
baselin
incid
male
higher
risk
patient
zikaassoci
gb
enceph
die
chronic
pain
describ
earlier
congenit
zika
syndrom
result
infect
pregnanc
associ
devast
abnorm
newborn
signific
impact
acut
infect
zika
viru
laboratori
find
may
reveal
leukopenia
lymphopenia
thrombocytopenia
less
frequent
leukocytosi
creactiv
protein
may
mildli
elev
well
transaminas
recommend
confirmatori
zika
viru
test
vari
among
countri
evolv
cours
rapid
spread
america
unit
state
test
constrain
avail
diagnost
test
laboratori
capabl
guidelin
consid
pregnanc
statu
patient
partner
exposur
histori
symptom
strongest
focu
pregnant
women
fig
chain
reaction
rtpcr
nucleic
acid
test
nat
rna
appear
detect
longer
whole
blood
urin
sampl
compar
serum
sampl
molecular
test
perform
serum
whole
blood
urin
week
symptom
onset
pregnant
women
nat
may
perform
week
symptom
onset
exposur
see
fig
detect
zika
igm
igmcaptur
enzymelink
immunosorb
assay
macelisa
follow
confirm
plaqu
reduct
neutral
test
prnt
also
establish
diagnosi
zika
igm
may
reactiv
perform
week
exposur
persist
longer
unfortun
zika
serolog
crossreact
flavivirus
prnt
need
differenti
among
flavivirus
labor
intens
time
consum
challeng
interpret
unlik
dengu
chikungunya
igg
avail
assess
past
infect
immun
zika
igg
avail
unit
state
food
drug
administr
fda
licens
diagnost
test
diagnosi
zika
viru
infect
sever
diagnost
test
avail
emerg
use
author
center
diseas
control
prevent
cdc
state
laboratori
perform
test
pcr
igm
cdc
perform
prnt
octob
fda
approv
first
zika
test
screen
blood
donat
main
differenti
diagnos
zika
viru
infect
virus
transmit
aed
mosquito
especi
dengu
also
flaviviru
chikungunya
alphaviru
zika
dengu
chikungunya
caus
similar
symptom
may
import
consequ
distinguish
three
arbovirus
molecular
test
serolog
follow
prnt
desir
diagnos
may
resembl
zika
viru
infect
includ
rubeola
rubella
parvoviru
west
nile
viru
mani
virus
well
leptospirosi
rickettsiosi
malaria
treatment
typic
uncompl
zika
viru
infect
aim
provid
symptomat
relief
known
specif
medic
target
zika
viru
howev
research
underway
assess
effect
exist
drug
zika
viru
preliminari
investig
identifi
candid
drug
emricasan
niclosamid
sofosbuvir
chloroquin
azithromycin
bovin
dengu
igm
serolog
also
perform
patient
risk
exposur
clinic
compat
ill
b
lactoferrin
evalu
need
regard
potenti
activ
zika
viru
current
vaccin
prevent
zika
viru
infect
multipl
candid
vaccin
develop
test
therefor
avoid
mosquito
bite
sexual
transmiss
fundament
prevent
impact
zika
viru
infect
consequenti
pregnanc
thu
prevent
infect
pregnant
women
crucial
key
messag
pregnant
women
partner
person
plan
concept
includ
follow
avoid
travel
area
activ
zika
viru
transmiss
take
measur
avoid
mosquito
bite
practic
safe
sex
reduc
risk
sexual
transmiss
area
activ
zika
viru
transmiss
vector
control
measur
essenti
updat
epidemiolog
test
recommend
cdc
websit
wwwcdcgovzika
valuabl
guid
clinic
practic
gregori
dey
michael
koren
alphaviru
transmit
anophelin
mosquito
subsaharan
africa
typic
report
larg
epidem
high
attack
rate
fever
sever
symmetr
arthralgia
nearli
univers
prurit
maculopapular
rash
common
lymphaden
especi
posterior
cervic
common
univers
diagnosi
polymeras
chain
reaction
pcr
first
day
serolog
treatment
support
acut
symptom
resolv
day
onyong
nyong
fever
onn
arbovir
diseas
caus
alphaviru
semliki
forest
complex
close
relat
chikungunya
viru
chikv
fig
like
member
complex
onyong
nyong
viru
onnv
caus
febril
arthralg
ill
uniqu
among
alphavirus
adapt
anophel
mosquito
vector
primarili
respons
transmiss
diseas
first
recogn
epidem
began
northwestern
uganda
end
epidem
involv
million
peopl
bandlik
distribut
across
uganda
kenya
tanzania
investig
epidem
led
discoveri
novel
viru
name
acholi
term
mean
joint
breaker
epidemiolog
onn
larg
describ
occur
epidem
subsaharan
africa
end
initi
epidem
clinic
case
recogn
subsequ
epidem
occur
uganda
result
sever
hundr
case
howev
sporad
case
report
sever
region
subsaharan
africa
outsid
recogn
epidem
furthermor
recent
serosurvey
coastal
kenya
demonstr
preval
onnv
antibodi
presenc
despit
report
recent
outbreak
region
ill
clinic
featur
similar
onn
describ
nigeria
caus
agent
origin
name
igbo
ora
viru
subsequ
studi
shown
igbo
ora
actual
strain
onnv
genet
similar
igbo
ora
onnv
onnv
togeth
serosurvey
kenya
cameroon
west
africa
suggest
least
level
unrecogn
endem
transmiss
occur
interepidem
period
recogn
epidem
rate
infect
high
area
affect
villag
viru
princip
transmit
anophel
funestu
gambia
also
serv
import
vector
malaria
vertebr
reservoir
identifi
risk
factor
infect
like
relat
risk
mosquito
exposur
like
similar
risk
factor
associ
malaria
ratio
symptomat
inappar
infect
roughli
incub
period
estim
day
clinic
symptom
typic
begin
sudden
onset
fever
joint
pain
joint
involv
gener
symmetr
involv
knee
ankl
elbow
wrist
finger
joint
pain
last
averag
day
although
durat
long
day
report
arthralgia
suffici
sever
lead
immobil
case
averag
day
headach
rash
also
commonli
report
clinic
case
rash
describ
maculopapular
descend
progress
head
trunk
extrem
typic
last
day
lymphadenopathi
also
commonli
describ
occur
often
cervic
region
also
inguin
axillari
area
case
suggest
distinguish
factor
onn
notabl
appear
occur
case
conjunctiv
suffus
also
report
approxim
half
case
mild
neutropenia
report
acut
phase
ill
epidem
epidem
report
fatal
despit
total
million
case
clinic
featur
lymphadenopathi
fever
arthralgia
import
characterist
featur
suffici
specif
exclud
similar
arboviru
infect
chikungunya
care
histori
physic
examin
direct
exclud
ill
well
find
support
featur
rash
viru
detect
whole
blood
molecular
amplif
polymeras
chain
reaction
pcr
greatest
sensit
first
day
onset
ill
serolog
help
establish
diagnosi
made
detect
specif
igm
pair
acut
convalesc
sera
show
develop
specif
igg
igm
typic
appear
second
week
ill
persist
month
long
month
case
igg
titer
begin
rise
day
longlast
care
must
taken
interpret
serolog
result
wellknown
oneway
crossreact
chikv
ie
patient
previous
infect
chikungunya
develop
crossreact
antibodi
onnv
antibodi
gener
onnv
infect
reliabl
crossreact
chikungunya
viru
ill
selflimit
therapi
nonsteroid
antiinflammatori
drug
nsaid
may
benefit
joint
symptom
prevent
measur
exposur
malaria
vectorsfor
exampl
insecticidetr
bed
net
indoor
residu
insecticidesshould
also
effect
control
epidem
onn
addit
vaccin
effort
aim
prevent
chikungunya
may
provid
protect
onnv
infect
due
product
crossreact
antibodi
ross
river
viru
rrv
mosquitoborn
viru
caus
sever
thousand
human
case
per
year
australia
polyarthralgia
polyarthr
predomin
clinic
featur
singlestrand
positivesens
rna
viru
kb
genom
belong
genu
alphaviru
famili
togavirida
viru
first
isol
aed
vigilax
mosquito
trap
besid
ross
river
queensland
fig
seri
outbreak
diseas
origin
call
epidem
polyarthr
epidemiolog
rrv
diseas
notifi
public
health
author
australia
common
arbovir
diseas
australia
mean
rang
report
case
per
year
equat
mean
nation
incid
rang
per
per
annum
period
data
avail
via
http
diseas
typic
occur
adult
year
old
clear
predomin
male
femal
symptomat
infect
rare
children
rrv
endem
australia
papua
new
guinea
case
occur
northern
australia
wet
season
usual
decemberfebruari
mosquito
number
high
rrv
caus
larg
epidem
south
pacif
see
fig
viru
may
still
circul
rrv
transmit
enzoot
cycl
macropod
kangaroo
wallabi
natur
vertebr
host
viru
transmit
human
vertebr
human
epidem
mosquito
princip
vigilax
camptorhynchu
culex
annulorostri
enzoot
transmiss
complex
ecolog
involv
multipl
host
vector
differ
mode
transmiss
differ
biogeograph
area
make
diseas
difficult
model
predict
henc
hinder
diseas
control
rheumat
diseas
believ
aris
adapt
innat
immun
respons
direct
rrv
antigen
rna
persist
affect
tissu
respons
produc
arthritogen
proinflammatori
mediat
joint
effus
predominantli
contain
mononuclear
cell
rrv
rna
detect
synovi
fluid
polymeras
chain
reaction
pcr
howev
joint
aspir
pcr
limit
valu
diagnosi
rrv
infect
subclin
asymptomatictosymptomat
ratio
virusspecif
antibodi
probabl
neutral
antibodi
believ
princip
protect
adapt
immun
respons
rrv
natur
acquir
immun
appear
lifelong
report
reinfect
incub
period
rrv
usual
day
rang
day
acut
diseas
typic
involv
polyarthralgia
polyarthr
patient
fever
rash
usual
maculopapular
andor
myalgia
joint
commonli
affect
multipl
peripher
small
joint
knee
usual
symmetr
pattern
tabl
effus
often
present
usual
small
symptom
includ
fatigu
headach
photophobia
lymphadenopathi
rrv
enceph
case
report
howev
causal
link
viru
unsupport
popular
misconcept
rrv
diseas
symptom
persist
year
howev
prospect
studi
use
valid
questionnair
illustr
patient
rrv
diseas
diagnos
symptom
usual
progress
resolv
month
longterm
sequela
detail
histori
help
especi
regard
resid
domest
intern
travel
season
rapid
onset
arthrit
symptom
usual
pain
movement
tender
slight
swell
hard
detect
common
sign
tender
swell
heat
red
intoler
movement
pressur
extrem
rash
usual
maculopapular
occur
within
day
onset
symptom
resolv
within
day
rash
distribut
vari
consider
trunk
limb
affect
face
less
affect
rare
rash
may
confin
palm
sole
digit
web
lymphadenopathi
frequent
present
sought
asid
fatigu
constitut
symptom
usual
resolv
within
week
diagnosi
usual
made
primarycar
physician
aid
commerci
serodiagnost
enzymelink
immunosorb
assay
elisa
base
test
wide
avail
australia
two
serolog
test
least
day
apart
recommend
peripher
blood
count
usual
normal
except
possibl
slight
neutrophilia
elev
erythrocyt
sediment
rate
occur
decreas
within
week
serum
creactiv
protein
level
rare
elev
eros
chang
seen
xray
altern
diagnos
sought
differenti
diagnos
initi
diseas
present
includ
relat
old
world
alphavirus
eg
chikungunya
barmah
forest
sindbi
viru
dengu
epsteinbarr
viru
viral
arthritid
may
also
consid
exampl
rubella
parvoviru
drug
reaction
autoimmun
arthritid
eg
rheumatoid
arthriti
infecti
arthritid
may
also
among
differenti
diagnos
persist
distinct
monoarticular
arthriti
inconsist
rrv
diseas
patient
diagnos
rrv
diseas
symptom
last
longer
month
differenti
diagnos
activ
sought
survey
rrv
diseas
patient
half
patient
report
diseas
last
longer
month
howev
nearli
patient
rheumat
condit
primarili
autoimmun
depress
subsequ
diagnos
evid
rrv
diseas
predispos
rheumat
diseas
may
contribut
postinfect
depress
fatigu
prevent
mosquito
bite
prevent
rrv
infect
insect
repel
contain
deet
recommend
except
infant
month
insect
screen
bed
net
longsleev
loosefit
lightcolor
cloth
also
protect
rrv
diseas
gener
treat
paracetamol
nonsteroid
antiinflammatori
drug
nsaid
mani
patient
satisfi
treatment
anecdot
evid
suggest
differ
nsaid
may
need
tri
standard
risk
contraind
nsaid
use
patient
condit
includ
asthma
peptic
ulcer
cardiovascular
renal
diseas
consid
aspirin
use
patient
recommend
chikungunya
steroid
gener
recommend
although
vaccin
test
phase
iii
human
trial
commerci
avail
oropouch
viru
orov
member
orthobunyaviru
genu
peribunyavirida
famili
caus
agent
oropouch
fever
first
case
oropouch
fever
describ
viru
isol
blood
sampl
febril
patient
west
indi
pool
coquillettidia
venezuel
ensi
mosquito
larg
epidem
record
brazil
involv
estim
peopl
past
five
decad
estim
half
million
peopl
infect
viru
tropic
area
south
central
america
mainli
amazon
region
brazil
peru
epidemiolog
orov
found
brazil
panama
peru
trinidad
tobago
basic
maintain
two
differ
life
cycl
one
occur
urban
area
tropic
citi
amazon
basin
involv
human
vertebr
host
culicoid
paraensi
midg
major
arthropod
vector
transmiss
gener
occur
outdoor
daytim
especi
sunris
sunset
describ
life
cycl
sylvat
well
understood
base
serolog
preval
involv
wild
mammal
especi
sloth
monkey
bird
potenti
vertebr
host
arthropod
vector
sylvat
life
cycl
unknown
may
includ
c
paraensi
mani
outbreak
oropouch
fever
character
epidem
spread
numer
villag
within
one
geograph
area
short
period
episod
essenti
occur
new
colon
area
suburb
larg
amazonian
urban
method
commonli
appli
molecular
method
revers
transcript
polymeras
chain
reaction
rtpcr
recent
realtim
pcr
show
excel
result
viru
isol
attempt
newborn
mice
hamster
day
vero
cell
cultur
viral
identif
suspens
prepar
brain
mice
supernat
infect
vero
cell
use
antigen
complement
fixat
immunofluoresc
assay
orov
hyperimmun
serum
recent
molecular
approach
use
genotyp
identif
isol
specif
identif
orov
neutral
hemagglutin
inhibit
test
also
perform
treatment
support
common
analges
use
reliev
headach
muscl
joint
pain
particular
treat
retrobulbar
pain
gener
sever
vaccin
avail
prevent
oropouch
fever
person
control
measur
recommend
includ
use
repel
center
spread
viru
probabl
consequ
circul
virem
peopl
local
transmit
vector
found
larg
concentr
suscept
individu
oropouch
fever
selflimit
febril
ill
fatal
record
use
molecular
type
method
four
differ
orov
genotyp
describ
america
littl
known
pathogenesi
oropouch
fever
humansmost
inform
pathogenesi
obtain
experiment
studi
golden
hamster
human
virem
period
anim
brief
reach
titer
high
enough
easili
infect
c
paraensi
midg
lethal
infect
hamster
intens
enceph
observ
promin
hepat
probabl
mechan
anim
death
clinic
oropouch
fever
character
sudden
onset
high
fever
headach
myalgia
arthralgia
anorexia
dizzi
chill
photophobia
patient
present
morbilliform
exanthem
resembl
rubella
dengu
nausea
vomit
diarrhea
conjunctiva
congest
epigastr
retroocular
pain
constitut
symptom
also
common
patient
may
display
pictur
asept
mening
other
temporari
enceph
recrudesc
mild
symptom
sever
day
wane
initi
febril
episod
commonli
seen
biphas
ill
recoveri
complet
individu
without
appar
sequela
even
sever
case
report
proven
lethal
caus
oropouch
fever
differenti
diagnosi
includ
caus
febril
ill
particularli
dengu
fever
chikungunya
fever
malaria
blood
sampl
collect
acut
phase
ill
day
onset
symptom
use
viru
detect
mayaro
viru
leukopenia
common
find
unspecif
laboratori
test
within
first
week
ill
white
cell
count
commonli
observ
platelet
count
liver
function
test
usual
normal
differenti
diagnosi
includ
caus
fever
arthralgia
rash
particularli
dengu
oropouch
chikungunya
zika
fever
virus
laboratori
diagnosi
mayaro
fever
either
depend
viru
isol
attempt
serolog
diagnost
molecular
method
genom
detect
viru
isol
biolog
sampl
serum
blood
obtain
virem
patient
day
onset
symptom
use
inocul
newborn
mice
vero
cell
suspens
prepar
brain
mice
supernat
infect
cell
use
antigen
either
complement
fixat
test
immunofluoresc
assay
hyperimmun
sera
differ
arbovirus
circul
region
specif
identif
mayaro
viru
carri
use
neutral
hemagglutin
inhibit
test
revers
transcript
rt
pcr
well
realtim
pcr
show
excel
result
treatment
support
patient
requir
hospit
death
report
theori
person
protect
mosquito
bite
insect
repel
long
sleev
trouser
protect
practic
forest
worker
bed
net
window
screen
littl
benefit
haemagogu
mosquito
day
biter
addit
vaccin
avail
prevent
mayaro
fever
natur
host
littl
known
pathogenesi
mayaro
fever
human
viru
associ
death
thu
materi
avail
histopatholog
examin
data
regard
pathogenesi
result
experiment
vitro
studi
use
vero
cell
cultur
indic
intens
cytopath
effect
cell
death
casein
kinas
import
role
mayaro
viru
infect
cycl
mayaro
fever
clinic
character
acut
febril
ill
gener
accompani
headach
myalgia
rash
chill
photophobia
dizzi
eye
pain
nausea
vomit
less
frequent
report
arthralgia
predominantli
affect
wrist
finger
ankl
toe
well
cutan
rash
also
commonli
observ
trunk
extrem
occasion
may
also
pain
joint
swell
persist
patient
arthralgia
last
year
aspect
consid
possibl
cocircul
mayv
chikungunya
viru
chikv
area
virus
member
semliki
forest
group
alphaviru
genu
high
crossreact
present
serolog
test
even
igmelisa
enzymelink
immunosorb
assay
thu
molecular
biolog
pathogen
longdist
dissemin
sft
occur
mainli
spring
summer
month
tick
densiti
highest
endem
area
human
contact
infect
tick
anim
like
highrisk
group
includ
farmer
rancher
forest
worker
other
live
rural
hilli
wood
area
persontoperson
transmiss
direct
contact
blood
bloodi
secret
report
sftsv
phylogenet
separ
two
clade
chines
japanes
virus
usual
though
alway
consist
geograph
origin
korean
strain
fall
within
japanes
clade
pathogenesi
sftsv
infect
gener
four
overlap
stage
incub
febril
ill
multiorgan
involv
convalesc
four
stage
may
occur
milder
infect
incub
period
gener
day
affect
viral
dose
rout
infect
viremia
peak
febril
ill
stage
day
fever
onset
high
viremia
may
associ
poor
outcom
high
viremia
occur
accompani
uncontrol
system
inflammatori
respons
multiorgan
involv
stage
viremia
gradual
fall
survivor
remain
high
fatal
case
viral
compon
detect
liver
spleen
lymph
node
bone
marrow
mark
thrombocytopenia
typic
sft
propos
due
splenic
macrophag
clearanc
circul
virusbound
platelet
clinic
featur
sft
present
nonspecif
febril
ill
sudden
onset
fever
last
day
headach
fatigu
malais
muscl
joint
pain
nauseavomit
diarrhea
accompani
thrombocytopenia
leukopenia
occur
almost
patient
abnorm
liver
function
test
multiorgan
involv
occur
day
ill
onset
last
day
progress
failur
fatal
case
selflimit
cours
survivor
progress
organ
failur
rapid
first
liver
heart
lung
kidney
one
fifth
patient
central
nervou
system
cn
manifest
includ
apathi
seizur
muscl
tremor
coma
death
occur
case
averag
time
ill
onset
death
day
poor
outcom
like
patient
advanc
age
decreas
conscious
underli
diseas
bleed
tendenc
elev
lactat
dehydrogenas
ldh
creatin
kinas
prolong
activ
partial
prothrombin
time
elev
creactiv
protein
diseas
cours
convalesc
period
survivor
begin
day
ill
onset
diagnosi
sft
consid
patient
present
fever
thrombocytopenia
leukopenia
spring
fall
histori
exposur
tick
relev
anim
endem
area
china
japan
south
korea
laboratori
diagnosi
consist
revers
transcriptas
polymeras
chain
reaction
rtpcr
avail
first
week
ill
virusspecif
igmigg
enzymelink
immunosorb
assay
elisa
first
week
clinic
present
nonspecif
differenti
diagnosi
broad
may
includ
scrub
typhu
rickettsi
infect
anaplasmosi
leptospirosi
q
fever
dengu
fever
endem
etiolog
treatment
prevent
specif
therapi
proven
improv
outcom
sft
treatment
support
consist
earli
diagnosi
manag
complic
bacteri
fungal
infect
ribavirin
shown
vitro
antivir
activ
sftsv
howev
clinic
benefit
genu
phleboviru
within
famili
phenuivirida
formerli
bunyavirida
order
bunyaviral
contain
virus
caus
human
diseas
includ
rift
valley
fever
sandfli
fever
recent
emerg
sever
fever
thrombocytopenia
syndrom
sft
heartland
viru
hrtv
diseas
transmiss
occur
tick
vector
mainli
haemaphysali
longicorni
anim
goat
cattl
sheep
yak
donkey
pig
cat
deer
rat
mice
hedgehog
weasel
brushtail
possum
chicken
bird
thought
serv
anim
reservoir
migratori
bird
act
carrier
h
longicornisborn
sftsv
may
import
demonstr
ribavirin
alon
perhap
due
suboptim
dose
andor
late
time
intervent
plasma
exchang
propos
benefit
administ
earli
ribavirin
plasma
exchang
combin
use
sft
patient
recov
plasma
exchang
follow
convalesc
serum
therapi
use
success
treat
case
sft
encephalopathi
therapi
need
confirm
studi
vaccin
avail
sft
prevent
consist
avoid
tick
bite
health
care
provid
adher
strict
contact
droplet
precaut
due
risk
environment
contamin
persontoperson
transmiss
especi
treat
critic
ill
patient
epidemiolog
hrtv
first
isol
two
patient
missouri
hand
case
document
sinc
mainli
older
men
midwestern
unit
state
histori
tick
bite
exposur
summer
month
transmiss
thought
occur
lone
star
tick
amblyomma
americanum
anim
reservoir
yet
confirm
although
neutral
antibodi
detect
varieti
anim
includ
hors
deer
raccoon
coyot
pathogenesi
pathogenesi
hrtv
well
understood
given
low
number
case
hrtv
detect
brain
thalamu
liver
gallbladd
pancrea
heart
lung
larg
small
bowel
kidney
test
addit
bone
marrow
lymph
node
splenic
tissu
clinic
featur
hrtv
diseas
present
fever
fatigu
headach
cough
joint
muscl
pain
nausea
diarrhea
leukopenia
thrombocytopenia
patient
confus
shortterm
memori
loss
last
sever
month
death
occur
least
two
confirm
case
wide
dissemin
viru
multiorgan
failur
diagnosi
hrtv
diseas
consid
older
men
midwestern
unit
state
nonspecif
febril
ill
histori
tick
bite
exposur
laboratori
diagnosi
perform
special
laboratori
use
rtpcr
igmigg
elisa
neutral
assay
differenti
diagnosi
may
includ
ehrlichiosi
anaplasmosi
west
nile
viru
infect
rickettsi
infect
leptospirosi
etiolog
treatment
prevent
specif
therapi
avail
clinic
manag
support
epidemiolog
sandfli
fever
caus
virus
within
sandfli
fever
napl
viru
sfnv
speci
includ
sandfli
fever
sicilian
viru
sfsv
sandfli
fever
turkey
viru
sftv
toscana
viru
toscana
viru
uniqu
among
sandflytransmit
phlebovirus
primarili
caus
cn
diseas
sandfli
fever
virus
found
subtrop
region
southern
europ
north
africa
eastern
mediterranean
iraq
iran
pakistan
afghanistan
india
affect
local
popul
well
travel
militari
personnel
deploy
area
sandfli
fever
virus
transmit
sandfli
phlebotomu
genu
humanvectorhuman
cycl
especi
warm
season
eg
april
octob
mediterranean
role
anim
reservoir
unclear
present
adult
femal
sandfli
bite
human
readili
pass
mosquito
bed
net
novel
sandfli
fever
virus
continu
identifi
may
respons
human
diseas
previous
thought
pathogenesi
incub
period
sandfli
fever
virus
usual
day
week
durat
viremia
typic
less
week
viral
load
cerebrospin
fluid
csf
usual
low
sindbi
viru
sinv
alphaviru
within
western
equin
enceph
viru
complex
like
alphavirus
singlestrand
positivesens
genom
contain
within
small
envelop
virion
viru
first
isol
culex
univittatu
mosquito
trap
sindbi
district
egypt
first
isol
human
whole
blood
febril
patient
uganda
first
major
recogn
outbreak
occur
south
africa
caus
hundr
case
diseas
character
rash
arthriti
describ
sweden
russia
finland
name
ockelbo
diseas
karelian
fever
pogosta
diseas
respect
subsequ
analysi
shown
elev
specif
igm
typic
detect
within
week
symptom
onset
persist
month
igg
gener
elev
day
symptom
onset
persist
specif
therapi
symptomat
therapi
nonsteroid
antiinflammatori
drug
nsaid
rest
may
provid
relief
although
effect
may
vari
individu
prevent
measur
includ
avoid
bite
culex
mosquito
seropreval
rate
vari
significantli
variou
endem
region
highest
rate
report
area
finland
south
africa
sindbi
fever
outbreak
notabl
report
conjunct
outbreak
west
nile
viru
infect
share
culex
mosquito
vector
major
infect
result
asymptomat
subclin
infect
approxim
case
manifest
clinic
symptom
incub
period
estim
day
common
symptom
report
patient
rash
arthralgia
occur
case
rash
typic
appear
trunk
limb
first
macul
progress
papul
lesion
usual
stage
develop
distribut
may
includ
four
extrem
includ
palm
sole
face
usual
spare
rash
may
persist
day
arthropathi
often
symmetr
may
occur
without
effus
joint
commonli
involv
includ
ankl
knee
finger
wrist
less
frequent
involv
hip
shoulder
neck
back
symptom
often
report
includ
fever
fatigu
myalgia
headach
report
approxim
half
symptomat
case
joint
symptom
persist
year
longer
may
caus
signific
degre
disabl
presenc
allel
significantli
associ
manifest
clinic
diseas
higher
rate
chronic
joint
pain
differenti
diagnosi
includ
consider
chikungunya
ross
river
viru
infect
base
geograph
locat
import
consider
includ
parvoviru
varicella
measl
along
noninfecti
rheumat
condit
revers
transcriptas
polymeras
chain
reaction
rtpcr
usual
ineffect
diagnosi
viremia
low
level
transient
diagnosi
typic
base
serolog
confirm
